Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

N-803-BCG combination shows promising results in BCG-unresponsive NMIBC

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

ASCO and WHO to collaborate on quality indicators for cancer facilities

The role of the Global Coalition for Radiotherapy in the war in Ukraine

COMy 2022: Multiple myeloma roundup

Youth Cancer Europe: Aiding Ukrainian refugees during the crisis

War in Ukraine: Impacts on the Slovakian cancer care system